PROPAFENONA ARENA 150mg tablets medication leaflet

C01BC03 propafenone • Cardiovascular system | Antiarrhythmics, class I and III | Antiarrhythmics, class Ic

Propafenone is a medication used to treat cardiac arrhythmias, such as atrial fibrillation or ventricular tachycardia. It belongs to the class Ic antiarrhythmics and works by slowing the conduction of electrical impulses in the heart, restoring normal heart rhythm.

The medication is taken orally, usually in tablet form, and should be used as directed by your doctor. It is important to monitor cardiac function during treatment to prevent complications.

Side effects may include dizziness, nausea, constipation, or fatigue. In rare cases, severe adverse effects such as worsening arrhythmias or heart failure may occur, requiring immediate medical attention.

Patients should inform their doctor about any other medications being used or pre-existing conditions, such as heart or liver diseases, to ensure the safe use of propafenone.

General data about PROPAFENONA ARENA 150mg

Substance: propafenone

Date of last drug list: 01-03-2017

Commercial code: W62994002

Concentration: 150mg

Pharmaceutical form: tablets

Quantity: 50

Product type: generic

Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Marketing authorisation

Manufacturer: ARENA GROUP S.A. - ROMANIA

Holder: ARENA GROUP S.A. - ROMANIA

Number: 9245/2016/02

Shelf life: 3 years

Pharmaceutical forms available for propafenone

Concentrations available for propafenone

150mg, 300mg, 35mg/10ml, 70mg/20ml

Other substances similar to propafenone